# FDA Inspection 756129 - Biomat USA Inc - October 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4b09699a-c7af-4e8f-84e4-8f2030dc5949
Source feed: FDA_Inspections

> FDA Inspection 756129 for Biomat USA Inc on October 28, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 756129
- Company Name: Biomat USA Inc
- Inspection Date: 2011-10-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1111584 - 2019-10-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ee67277e-9149-421a-94a9-fa056bb0d495)
- [FDA Inspection 1029272 - 2017-08-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/361f2001-62b6-4496-9eec-664836e4bd57)
- [FDA Inspection 981277 - 2016-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/71ad1ff9-7ae2-45dc-9e4e-68e38e7a6cce)
- [FDA Inspection 869727 - 2014-03-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/97ae92cd-6f58-4c8f-97a3-dd712cbe2aa2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/f4246f7c-dd27-450c-a8f8-ea73caedb0dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d